New Compounds for the Treatment of Pulmonary Hypertension

Cardiovascular Medicine
doi 10.4414/cvm.2018.00556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

ERJOctober Podcast: New Guidelines for Diagnosis and Treatment of Pulmonary Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2014English

Treatment of Pulmonary Hypertension

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2014English

Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Future Perspectives for the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2009English

New Possibilities in the Treatment of Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension in Ukraine

HYPERTENSION
2018English

New Treatment Options for Pulmonary Arterial Hypertension — The First Selective IP-receptor Agonist Selexipag

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2019English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy